Medical Foods Market 2021-26: Size, Share, Trends, Demand, Growth And Forecast
According to the latest report by IMARC Group, titled, “Medical Foods Market Size:Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026″, the medical foods market exhibited moderate growth during 2015-2020. and expected to at a CAGR of around 5% during the next five years
Medical foods are consumed under the supervision of a physician or intended for the dietary management of different diseases and conditions. These food products comprise vitamins, minerals, botanicals, coenzymes, omega-2 fatty acids, taurine, and antioxidants. They aid in enhancing the immune and digestive systems and managing nutritional deficiencies. At present, they are available in the form of pills, puddings and pre-thickened products, and powder and liquids for oral intake around the world.
A significant increase in the prevalence of chronic diseases represents one of the major factors impelling the growth of the market. Medical foods are recommended by physicians as they aid in managing the symptoms of multiple sclerosis, neurological conditions, dementia, and stroke. Additionally, growing awareness about the need for clinical nutrition among healthcare professionals and patients is catalyzing the demand further. Besides this, the increasing internet penetration is boosting product sales via e-commerce websites.
Request Free Sample Report: https://www.imarcgroup.com/medical-foods-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global Medical Foods Mark 2021-2026 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Abbott Laboratories, Alfasigma S.p.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company LLC (Reckitt Benckiser), Medtrition Inc., Meiji Holdings Co. Ltd., Metagenics Inc. (Alticor), Nestlé S.A., Primus Pharmaceuticals Inc., Targeted Medical Pharma Inc. and Victus Inc.
The report has segmented the market on the basis on region, product, route of administration, application and distribution channel.
Breakup by Product:
Breakup by Route of Administration:
Breakup by Application:
- Alzheimer’s Disease
- Metabolic Disorders
Breakup by Distribution Channel:
- Hospital and Retail Pharmacies
- Online Pharmacies
Breakup by Region:
- North America: (United States, Canada)
- Asia-Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, RussiaOthers
- Latin America: (Brazil, Mexico,Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/medical-foods-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA
Tel No:(D) +91 120 433 0800 |
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800